Ascendis reports sustained growth in achondroplasia trial subgroup
Go back to Ascendis reports sustained growth in achondroplasia trial subgroup| Asianada, Inc. (NASDAQ: ASND) | Delayed: 233.87 +5.87 (2.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $228.00 | 52 Week High | $21.79 | |||
| Open | $228.00 | 52 Week Low | $11.92 | |||
| Day High | $237.37 | P/E | N/A | |||
| Day Low | $222.82 | EPS | $-0.07 | |||
| Volume | 470,423 | |||||
